ClinicalTrials.Veeva

Menu

Diffusion -and Perfusion Weighted MRI for Response Prediction of Symptomatic Leiomyomas Following Uterine Artery Embolization

U

Universitaire Ziekenhuizen KU Leuven

Status

Active, not recruiting

Conditions

Leiomyomas

Treatments

Procedure: Diffusion -and perfusion weighted MRI including iv contrast agent injection

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

It is known that volumetric response of leiomyomas following uterine artery embolization correlates well with patients clinical outcome. The aim of this study is to assess diffusion -and perfusion weighted MRI for the prediction of volumetric response following uterine artery embolization in patients with symptomatic leiomyomas.

Enrollment

100 estimated patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

  • women with symptomatic leiomyomas

Exclusion criteria

  • women with known contra-indications for MRI (cardiac pacemaker, cochlear implants, claustrophobic patients)
  • women with contra-indications to gadolinium-based contrast agents (including patients with a known restricted renal function; GFR < 30 mL/min)

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

Single Blind

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems